Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Immune and Viral Outcomes of HIV-1 Therapy Interruption

This study has been completed.
Information provided by (Responsible Party):
Luis Montaner, The Wistar Institute Identifier:
First received: January 16, 2003
Last updated: February 8, 2016
Last verified: December 2005